A quality defect was found: too low boric acid content (should be 2.8%–3.2%, actual 0.3%) and non‑compliant form, which may lead to preparation of compounded medicines with incorrect strength and effectiveness. Potential effects: lack of drug efficacy, risk of therapy complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use this raw material for compounding medicines. Pharmacies should check their stocks of 3% boric acid solution from Zakład Farmaceutyczny “Amara” and return them according to the withdrawal pr...
The Chief Pharmaceutical Inspector decided to withdraw from the market throughout the country the specified batch of the pharmaceutical raw material 3% boric acid solution and granted the decision imm...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related